A new drug maker, MARINUS Pharmaceuticals, has been granted a license to sell an insulin treatment that was developed using a technology called gene therapy.The company’s application was submitted Thursday by a regulatory committee in the United States.MARINAS patent covers the use of a gene therapy to treat multiple sclerosis.The company says the drug is […]

Continue Reading...